Oct 25, 2023, 17:52
Ilya Tsimafeyeu: Patients with metastatic renal cell carcinoma and high fibrinogen levels who received nivolumab had worse overall survival
Ilya Tsimafeyeu, Director at Bureau of Cancer ReĀsearch Russia, shared on Facebook:
“Our study: Patients with metastatic renal cell carcinoma and high fibrinogen levels who received nivolumab had worse overall survival.”
For further information click here.
Source: Ilya Tsimafeyeu/Facebook
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 26, 2024, 18:47
Sep 26, 2024, 18:26
Sep 26, 2024, 18:13
Sep 26, 2024, 18:07
Sep 26, 2024, 17:57
Sep 26, 2024, 17:40